Cleared Traditional

K903161 - MC II (TM), MODEL 7200S

K903161 is an FDA 510(k) clearance for MC II (TM), manufactured by Medical Devices, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 252-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1991
Decision
252d
Days
Class 2
Risk

K903161 is an FDA 510(k) clearance for the MC II (TM), MODEL 7200S. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Medical Devices, Inc. (St. Paul, US). The FDA issued a Cleared decision on March 27, 1991 after a review of 252 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K903161

510(k) Number K903161 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 1990
Decision Date March 27, 1991
Days to Decision 252 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
103d slower than avg
Panel avg: 149d · This submission: 252d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K903161.
MODEL SW-103 SOLITANS STIMULATOR
K904264 · Medical Consultants Intl. , Ltd. · May 1991
GLOBALCARE MICRO 11 AND MICROCARE (TENS)
K903394 · Globalcare Intl., Inc. · May 1991
DIAL-AWAY PAIN
K904457 · R.F.P., Inc. · Apr 1991
DYNATRON 200 MICROCURRENT
K903577 · Dynatronics Corp. · Mar 1991
SYNAPS (TM)
K903828 · Henley Intl. · Jan 1991
STIMTRAC PC, CATALOG NO. 78-8510
K903128 · Stimtech Products · Jan 1991